Preprint: Please note that this article has not completed peer review.
Research article

An assessment for Diagnostic and Therapeutic Modalities for Management of Pediatric Iron Defficiency Anemia in Saudi Arabia: a Crossectional Study

Hadi J Al Sulayyim, Ali Al Omari, Motasim Badri

Abstract

Background: Iron deficiency anemia (IDA) is a global public health issue that affect more than 2 billion individuals worldwide. However evidence for optimal management of IDA is lacking. Objectives: To assess the diagnostic criteria and therapeutic modalities for pediatric IDA employed by physicians in a major public healthcare facility in Riyadh. Methodology: A validated questionnaire including demographic data and patient case-scenarios related to diagnosis and treatment of IDA was employed. Robust regression analysis was used to identify factors associated with overall score of participants. Results: Of the 166 physicians surveyed 147(88.6%) were included in the study. Wide variability was observed in IDA diagnosis and therapy practises. For nutritional IDA, only 15.6% recommended no other laboratory tests in addition to CBC. The majority preferred treatment with ferrous sulfate (77.6%) divided into two doses (57.1%), but the total daily elemental iron doses varied widely from 2 to 6 mg/kg. For intravenous iron, 42.9% recommended iron dextran, 32.7% iron sucrose, and 13.4% would continue oral iron. Of all assessed factors, median score was significantly highest in pediatric hematologists compared with pediatricians, family medicine specialists and GPs; p=0.007, and those work in tertiary care compared with those in primary care; p=0.043. However, in multivariate robust regression analysis, overall score was only significantly associated with professional qualification pediatric hematologist β=13.71,95%CI 2.48-24.95, p=0.017; pediatrician β=1.77,95%C (-6.05-9.59, p=0.66; family medicine β=2.66,95%CI-4.30-9.58, p=0.45 compared with general practitioner. Conclusion: Wide variations exist among physicians in diagnosis and treatment of pediatric IDA. Intervention programs and national guidelines are urgently needed.

Keywords
Iron deficiency anemia; treatment; diagnosis; assessment; pediatric.

Introduction

Patients and Methods

Results

Discussion

Conclusion

Abbreviations

Declarations

References

Tables

STATUS: In Review

Comments: 0
PDF Downloads: 0
HTML Views: 5

Integrity Check:

Peer Review Timeline

Version 2

Posted 13 Aug, 2019

  • No community comments so far
  • Reviewer #2 agreed

    On 15 Aug, 2019

  • 2 reviewer(s) invited

    Invitations sent on 15 Aug, 2019

  • Reviewer #1 agreed

    On 15 Aug, 2019

  • Review #1 received

    Received 15 Aug, 2019

  • Review #2 received

    Received 15 Aug, 2019

  • Editor assigned

    On 29 Jul, 2019

  • Submission checks complete

    On 28 Jul, 2019

  • Editor invited

    On 28 Jul, 2019

Version 1

Posted 12 Jul, 2019

View this version

Subject Areas

Pediatrics

More from BMC Pediatrics

Comments (0)

Comments can take the form of short reviews, notes or questions to the author. Comments will be posted immediately, but removed and moderated if flagged.

Learn more about our company.

Preprint: Please note that this article has not completed peer review.
Research article

An assessment for Diagnostic and Therapeutic Modalities for Management of Pediatric Iron Defficiency Anemia in Saudi Arabia: a Crossectional Study

Hadi J Al Sulayyim, Ali Al Omari, Motasim Badri

STATUS: In Review

Comments: 0
PDF Downloads: 0
HTML Views: 5

Integrity Check:

  • Article

  • Peer Review Timeline

  • Related Articles

  • Comments

Abstract

Background: Iron deficiency anemia (IDA) is a global public health issue that affect more than 2 billion individuals worldwide. However evidence for optimal management of IDA is lacking. Objectives: To assess the diagnostic criteria and therapeutic modalities for pediatric IDA employed by physicians in a major public healthcare facility in Riyadh. Methodology: A validated questionnaire including demographic data and patient case-scenarios related to diagnosis and treatment of IDA was employed. Robust regression analysis was used to identify factors associated with overall score of participants. Results: Of the 166 physicians surveyed 147(88.6%) were included in the study. Wide variability was observed in IDA diagnosis and therapy practises. For nutritional IDA, only 15.6% recommended no other laboratory tests in addition to CBC. The majority preferred treatment with ferrous sulfate (77.6%) divided into two doses (57.1%), but the total daily elemental iron doses varied widely from 2 to 6 mg/kg. For intravenous iron, 42.9% recommended iron dextran, 32.7% iron sucrose, and 13.4% would continue oral iron. Of all assessed factors, median score was significantly highest in pediatric hematologists compared with pediatricians, family medicine specialists and GPs; p=0.007, and those work in tertiary care compared with those in primary care; p=0.043. However, in multivariate robust regression analysis, overall score was only significantly associated with professional qualification pediatric hematologist β=13.71,95%CI 2.48-24.95, p=0.017; pediatrician β=1.77,95%C (-6.05-9.59, p=0.66; family medicine β=2.66,95%CI-4.30-9.58, p=0.45 compared with general practitioner. Conclusion: Wide variations exist among physicians in diagnosis and treatment of pediatric IDA. Intervention programs and national guidelines are urgently needed.

Introduction

Patients and Methods

Results

Discussion

Conclusion

Abbreviations

Declarations

References

Tables

Learn more about our company.